BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  OS Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

  May 16, 2025

   · 

  8 min read
• Press Releases

  Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension

  May 16, 2025

   · 

  9 min read
• Press Releases

  BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

  May 16, 2025

   · 

  7 min read
• Press Releases

  STAAR Surgical Announces $30 Million Share Repurchase Authorization

  May 16, 2025

   · 

  6 min read
• Press Releases

  Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

  May 16, 2025

   · 

  5 min read
• Press Releases

  PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

  May 16, 2025

   · 

  3 min read
• Press Releases

  Marea Therapeutics Announces Publication in The Lancet of Positive Data from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease

  May 16, 2025

   · 

  3 min read
• Press Releases

  Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

  May 16, 2025

   · 

  1 min read
• Press Releases

  Neurocrine Biosciences to Present Wide-Ranging One-Year Data from Phase 3 CAHtalyst™ Pediatric Study at Pediatric Endocrine Society 2025 Annual Meeting

  May 16, 2025

   · 

  13 min read
• Press Releases

  Sarepta Therapeutics Presents Data at the American Society of Gene & Cell Therapy Conference, Including Statistically Significant Functional Outcomes for 8- and 9-Year-Old Patients in New Data Analysis of EMBARK Part 2

  May 16, 2025

   · 

  13 min read